title: Methadone maintenance treatment: outcomes from the Otago methadone programme.
abstract: OBJECTIVE
  To provide information on methadone treatment outcomes for opiate-dependent individuals.
  
  
  METHODS
  Questionnaires and random urine tests were completed for 112 Otago clients comparing outcomes before and during methadone maintenance treatment.
  
  
  RESULTS
  Treatment retention rates were high, with 86% of clients remaining on the programme six months or more. The number of clients on benefits reduced by almost 30% during treatment, with employment rates doubling from 19% to 40% (including attendance at educational programmes). For the 89 clients injecting opiates daily at initial presentation, 64% reported no opiate use in the three months prior to review. Of the remaining 36%, opiate use reduced significantly. Rates of sharing injecting equipment reduced by almost 90%. Almost 50% of cannabis users reduced their use from daily to less than daily use. Clients reporting no current use of illicit benzodiazepines increased by 85%. Heavy binge drinking weekly or more reduced by almost 75%. Use of other illicit drugs reduced by almost 90%. Drug-related convictions reduced by almost 60%, while accidental drug overdoses reduced by over 90%.
  
  
  CONCLUSIONS
  The widespread benefits of methadone maintenance treatment demonstrated underline the importance of making quality methadone programmes readily accessible within the health system. Currently, there are long waiting lists and many individuals cannot gain access to active treatment. We believe the health system urgently needs to look at expanding existing services and/or establishing private methadone clinics similar to those in New South Wales.
authors.affiliation: University of Sydney, Gladesville Macquarie Hospital, NSW, Australia.
authors.forename: G M
authors.initials: GM
authors.lastname: Dore
authors.forename: J D
authors.initials: JD
authors.lastname: Walker
authors.forename: J R
authors.initials: JR
authors.lastname: Paice
authors.forename: S
authors.initials: S
authors.lastname: Clarkson
mesh_terms: D000293:Adolescent; D000328:Adult; D000701:Analgesics, Opioid / Q000627:therapeutic use*; D003153:Community Health Services; D005260:Female; D006801:Humans; D008297:Male; D008691:Methadone / Q000627:therapeutic use*; D009520:New Zealand; D009293:Opioid-Related Disorders / Q000534:rehabilitation*; D016896:Treatment Outcome
chemical_list: D000701:Analgesics, Opioid; D008691:Methadone